Reactivity studies detail nickel complex substitution with phosphines and silylenes, indicating diverse complexes.
Reactivity studies on the nickel complex [Ni(Mes2NHSi)2(COD)] (1), ligated with the N-heterocyclic silylene 1,3-bis(2,6-dimesityl)-1,3-diaza-2-silacyclopent-4-en-2-ylidene (= Mes2NHSi; COD = 1,5-cyclooctadiene) are presented. Treatment of 1 with two equivalents of the phosphines PMe3, PEt3 and PnBu3, and the N-heterocyclic carbene 1,3,4,5-tetramethyl-imidazolin-2-ylidene (IMeMe) led to substitution of the COD (and not the NHSi) ligand to yield the heteroleptic substituted complexes [Ni(Mes2NHSi)2(L)2] (L = PMe3 (2), PEt3 (3), PnBu3 (4), IMeMe (5)) in good yields. The reaction of [Ni(Mes2NHSi)2(COD)] with IiPrMe (1,3-diisopropyl-4,5-dimethyl-imidazolin-2-ylidene) and the reaction of [Ni(IiPrMe)2(η2-COE)] (COE = cyclooctene) with Mes2NHSi afforded mixtures of heteroleptic three-coordinated nickel complexes [Ni(Mes2NHSi)2(IiPrMe)] (6) and [Ni(Mes2NHSi)(IiPrMe)2] (7). Complex 1 reacts with carbon monoxide also under substitution of the COD ligand to afforded mixtures of mononuclear [Ni(Mes2NHSi)2(CO)2] (8) and dinuclear, silylene-bridged [{Ni(μ-Mes2NHSi)(CO)2}2] (9). Treatment of [Ni(CO)4] with Mes2NHSi also led to formation of the complexes 8 and 9, and, in addition, to the trinuclear Chini-type cluster complex [Ni3(μ-Mes2NHSi)2(μ-CO)2(CO)3] (10). In contrast to known related complexes of NHCs, complex 1 does not react with aryl fluorides and aryl chlorides and decomposes in the reaction with organyl bromides and iodides.
No takes yet. Share an insight, caveat, or question.
Glok et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: